Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines

Keisuke Aoe, Katsuyuki Kiura, Hiroshi Ueoka, Masahiro Tabata, Tadashi Matsumura, Masakazu Chikamori, Akio Matsushita, Hiroyuki Kohara, Mine Harada

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Docetaxel shows substantial activity against lung cancer. To find the optimal drug combination for docetaxel, we evaluated the effects of cisplatin, etoposide, mitomycin C, irinotecan, vindesine, and vinorelbine using three human lung cancer cell lines, ABC-1, EBC-1, and SBC-3. Drug cytotoxicity was determined by MTT assay. Tumor cells were incubated for 96 hours in the presence of docetaxel and each of the test drugs stated above. The combined drug interaction was evaluated by median-effect plot analysis and improved IC50-isobologram analysis. Both methods showed strong antagonism (subadditive or protective effect) between docetaxel and cisplatin displayed additive effects on all cell lines tested, when evaluated by improved IC50-isobologram analysis. The combination of docetaxel and vinorelbine exerted synergistic effect on the growth inhibition of SBC-3 cells, which showed a wide range of fractional cytotoxicity when analyzed by median-effect plot and supradditive when analyzed by improved IC50-isobologram. These observations suggest a possibility that docetaxel can be used in combination with vinorelbine or cisplatin in the treatment of lung cancer.

Original languageEnglish
Pages (from-to)291-299
Number of pages9
JournalAnticancer Research
Volume19
Issue number1 A
Publication statusPublished - 1999

Fingerprint

docetaxel
Cisplatin
Lung Neoplasms
Cell Line
Inhibitory Concentration 50
irinotecan
Vindesine
Mitomycin
Etoposide
Drug Combinations
Drug Interactions
Pharmaceutical Preparations
vinorelbine

Keywords

  • Cisplatin
  • Docetaxel
  • Etoposide
  • Improved IC50-isobologram
  • Lung cancer
  • Median-effect plot analysis
  • Vinorelbine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Aoe, K., Kiura, K., Ueoka, H., Tabata, M., Matsumura, T., Chikamori, M., ... Harada, M. (1999). Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. Anticancer Research, 19(1 A), 291-299.

Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. / Aoe, Keisuke; Kiura, Katsuyuki; Ueoka, Hiroshi; Tabata, Masahiro; Matsumura, Tadashi; Chikamori, Masakazu; Matsushita, Akio; Kohara, Hiroyuki; Harada, Mine.

In: Anticancer Research, Vol. 19, No. 1 A, 1999, p. 291-299.

Research output: Contribution to journalArticle

Aoe, K, Kiura, K, Ueoka, H, Tabata, M, Matsumura, T, Chikamori, M, Matsushita, A, Kohara, H & Harada, M 1999, 'Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines', Anticancer Research, vol. 19, no. 1 A, pp. 291-299.
Aoe, Keisuke ; Kiura, Katsuyuki ; Ueoka, Hiroshi ; Tabata, Masahiro ; Matsumura, Tadashi ; Chikamori, Masakazu ; Matsushita, Akio ; Kohara, Hiroyuki ; Harada, Mine. / Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines. In: Anticancer Research. 1999 ; Vol. 19, No. 1 A. pp. 291-299.
@article{f119b206d2234f1d9c0a11000c973f9a,
title = "Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines",
abstract = "Docetaxel shows substantial activity against lung cancer. To find the optimal drug combination for docetaxel, we evaluated the effects of cisplatin, etoposide, mitomycin C, irinotecan, vindesine, and vinorelbine using three human lung cancer cell lines, ABC-1, EBC-1, and SBC-3. Drug cytotoxicity was determined by MTT assay. Tumor cells were incubated for 96 hours in the presence of docetaxel and each of the test drugs stated above. The combined drug interaction was evaluated by median-effect plot analysis and improved IC50-isobologram analysis. Both methods showed strong antagonism (subadditive or protective effect) between docetaxel and cisplatin displayed additive effects on all cell lines tested, when evaluated by improved IC50-isobologram analysis. The combination of docetaxel and vinorelbine exerted synergistic effect on the growth inhibition of SBC-3 cells, which showed a wide range of fractional cytotoxicity when analyzed by median-effect plot and supradditive when analyzed by improved IC50-isobologram. These observations suggest a possibility that docetaxel can be used in combination with vinorelbine or cisplatin in the treatment of lung cancer.",
keywords = "Cisplatin, Docetaxel, Etoposide, Improved IC50-isobologram, Lung cancer, Median-effect plot analysis, Vinorelbine",
author = "Keisuke Aoe and Katsuyuki Kiura and Hiroshi Ueoka and Masahiro Tabata and Tadashi Matsumura and Masakazu Chikamori and Akio Matsushita and Hiroyuki Kohara and Mine Harada",
year = "1999",
language = "English",
volume = "19",
pages = "291--299",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1 A",

}

TY - JOUR

T1 - Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines

AU - Aoe, Keisuke

AU - Kiura, Katsuyuki

AU - Ueoka, Hiroshi

AU - Tabata, Masahiro

AU - Matsumura, Tadashi

AU - Chikamori, Masakazu

AU - Matsushita, Akio

AU - Kohara, Hiroyuki

AU - Harada, Mine

PY - 1999

Y1 - 1999

N2 - Docetaxel shows substantial activity against lung cancer. To find the optimal drug combination for docetaxel, we evaluated the effects of cisplatin, etoposide, mitomycin C, irinotecan, vindesine, and vinorelbine using three human lung cancer cell lines, ABC-1, EBC-1, and SBC-3. Drug cytotoxicity was determined by MTT assay. Tumor cells were incubated for 96 hours in the presence of docetaxel and each of the test drugs stated above. The combined drug interaction was evaluated by median-effect plot analysis and improved IC50-isobologram analysis. Both methods showed strong antagonism (subadditive or protective effect) between docetaxel and cisplatin displayed additive effects on all cell lines tested, when evaluated by improved IC50-isobologram analysis. The combination of docetaxel and vinorelbine exerted synergistic effect on the growth inhibition of SBC-3 cells, which showed a wide range of fractional cytotoxicity when analyzed by median-effect plot and supradditive when analyzed by improved IC50-isobologram. These observations suggest a possibility that docetaxel can be used in combination with vinorelbine or cisplatin in the treatment of lung cancer.

AB - Docetaxel shows substantial activity against lung cancer. To find the optimal drug combination for docetaxel, we evaluated the effects of cisplatin, etoposide, mitomycin C, irinotecan, vindesine, and vinorelbine using three human lung cancer cell lines, ABC-1, EBC-1, and SBC-3. Drug cytotoxicity was determined by MTT assay. Tumor cells were incubated for 96 hours in the presence of docetaxel and each of the test drugs stated above. The combined drug interaction was evaluated by median-effect plot analysis and improved IC50-isobologram analysis. Both methods showed strong antagonism (subadditive or protective effect) between docetaxel and cisplatin displayed additive effects on all cell lines tested, when evaluated by improved IC50-isobologram analysis. The combination of docetaxel and vinorelbine exerted synergistic effect on the growth inhibition of SBC-3 cells, which showed a wide range of fractional cytotoxicity when analyzed by median-effect plot and supradditive when analyzed by improved IC50-isobologram. These observations suggest a possibility that docetaxel can be used in combination with vinorelbine or cisplatin in the treatment of lung cancer.

KW - Cisplatin

KW - Docetaxel

KW - Etoposide

KW - Improved IC50-isobologram

KW - Lung cancer

KW - Median-effect plot analysis

KW - Vinorelbine

UR - http://www.scopus.com/inward/record.url?scp=0032922354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032922354&partnerID=8YFLogxK

M3 - Article

C2 - 10226557

AN - SCOPUS:0032922354

VL - 19

SP - 291

EP - 299

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1 A

ER -